These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 9857110

  • 1. Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.
    Barber MD, Fearon KC, Ross JA.
    Clin Sci (Lond); 1999 Jan; 96(1):83-7. PubMed ID: 9857110
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T, Yazici H, Guerne PA.
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
    Perini P, Tiberio M, Sivieri S, Facchinetti A, Biasi G, Gallo P.
    Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
    [Abstract] [Full Text] [Related]

  • 8. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K, Segami N, Sun W, Sato J, Fujimura K.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [Abstract] [Full Text] [Related]

  • 9. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.
    Iglesias J, Marik PE, Levine JS, Norasept II Study Investigators.
    Am J Kidney Dis; 2003 Jan; 41(1):62-75. PubMed ID: 12500222
    [Abstract] [Full Text] [Related]

  • 10. Hepatic regeneration induces transient acute phase reaction: systemic elevation of acute phase reactants and soluble cytokine receptors.
    Fulop AK, Pocsik E, Brozik M, Karabelyos C, Kiss A, Novak I, Szalai C, Dobozy O, Falus A.
    Cell Biol Int; 2001 Jan; 25(7):585-92. PubMed ID: 11448096
    [Abstract] [Full Text] [Related]

  • 11. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association.
    Knobler H, Zhornicky T, Sandler A, Haran N, Ashur Y, Schattner A.
    Am J Gastroenterol; 2003 Dec; 98(12):2751-6. PubMed ID: 14687828
    [Abstract] [Full Text] [Related]

  • 12. Dynamics of diurnal changes in serum concentration of TNF-alpha soluble receptors in gastrointestinal cancer patients.
    Muc-Wierzgoń M, Baranowski MM, Madej K, Wierzgoń J, Kokot T, Brodziak A.
    J Biol Regul Homeost Agents; 2000 Dec; 14(3):204-8. PubMed ID: 11037054
    [Abstract] [Full Text] [Related]

  • 13. Increase of anti-inflammatory cytokines in patients with esophageal cancer after perioperative treatment with G-CSF.
    Hübel K, Mansmann G, Schäfer H, Oberhäuser F, Diehl V, Engert A.
    Cytokine; 2000 Dec; 12(12):1797-800. PubMed ID: 11097751
    [Abstract] [Full Text] [Related]

  • 14. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V.
    Med Sci Monit; 2000 Dec; 6(4):661-7. PubMed ID: 11208388
    [Abstract] [Full Text] [Related]

  • 15. Poly-C specific ribonuclease activity correlates with increased concentrations of IL-6, IL-8 and sTNFR55/sTNFR75 in plasma of patients with acute pancreatitis.
    Naskalski JW, Kusnierz-Cabala B, Panek J, Kedra B.
    J Physiol Pharmacol; 2003 Sep; 54(3):439-48. PubMed ID: 14566081
    [Abstract] [Full Text] [Related]

  • 16. Relation between pro- and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis.
    Groeneveld PH, Kwappenberg KM, Langermans JA, Nibbering PH, Curtis L.
    Cytokine; 1997 Feb; 9(2):138-42. PubMed ID: 9071565
    [Abstract] [Full Text] [Related]

  • 17. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E, Pietruska Z.
    Arch Immunol Ther Exp (Warsz); 1997 Feb; 45(5-6):449-53. PubMed ID: 9437501
    [Abstract] [Full Text] [Related]

  • 18. Increased serum levels of soluble tumor necrosis factor a-receptors in patients undergoing partial liver resection.
    Schroder J, Gallati H, Kremer B.
    Hepatogastroenterology; 1998 Feb; 45(23):1807-12. PubMed ID: 9840152
    [Abstract] [Full Text] [Related]

  • 19. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V.
    Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
    [Abstract] [Full Text] [Related]

  • 20. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma.
    Urbańska-Ryś H, Wiersbowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2000 Sep; 11(3):443-51. PubMed ID: 11022130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.